Ambani Orgochem Limited (NSE:AMBANIORGO)
India · Delayed Price · Currency is INR 131.40
0.00 (0.00%)
At close: Feb 19, 2026
Ambani Orgochem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 2,199 | 1,925 | 1,362 | 1,320 | 1,250 | 866.65 |
Other Revenue | - | - | - | 4.46 | 2.69 | 1.13 |
| 2,199 | 1,925 | 1,362 | 1,325 | 1,253 | 867.78 | |
Revenue Growth (YoY) | 41.19% | 41.36% | 2.81% | 5.77% | 44.34% | 18.63% |
Cost of Revenue | 1,619 | 1,468 | 1,067 | 1,093 | 1,046 | 707.52 |
Gross Profit | 580.75 | 457.55 | 295.47 | 231.57 | 206.23 | 160.26 |
Selling, General & Admin | 80.19 | 81.26 | 83.97 | 42.63 | 42.58 | 32.62 |
Other Operating Expenses | 382.97 | 281.13 | 164.97 | 104.68 | 95.94 | 66.98 |
Operating Expenses | 497.56 | 392.76 | 276.8 | 161.88 | 152.64 | 109.88 |
Operating Income | 83.19 | 64.79 | 18.67 | 69.69 | 53.59 | 50.39 |
Interest Expense | -66.07 | -63.94 | -57.93 | -33.25 | -19.32 | -21.33 |
Interest & Investment Income | 11.47 | 11.47 | 2.37 | 1.96 | 2.08 | 1.77 |
Currency Exchange Gain (Loss) | 0.73 | 0.73 | 1.95 | 0.63 | 5.36 | 1.85 |
Other Non Operating Income (Expenses) | -2.41 | -14.35 | -10.36 | -8.81 | -13.27 | -8.83 |
EBT Excluding Unusual Items | 26.92 | -1.28 | -45.3 | 30.22 | 28.44 | 23.84 |
Gain (Loss) on Sale of Investments | - | - | - | 0.01 | 0.17 | 0.01 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.67 | - |
Other Unusual Items | 4.88 | 4.88 | 47.29 | -0.46 | - | 0.54 |
Pretax Income | 31.8 | 3.59 | 1.99 | 30.15 | 28.03 | 26.11 |
Income Tax Expense | 21.25 | 12.8 | -28.05 | 10.38 | 7.92 | 9.09 |
Earnings From Continuing Operations | 10.55 | -9.21 | 30.04 | 19.77 | 20.11 | 17.02 |
Minority Interest in Earnings | 0 | - | - | -0 | -0 | -0 |
Net Income | 10.55 | -9.21 | 30.04 | 19.77 | 20.11 | 17.01 |
Preferred Dividends & Other Adjustments | 6.83 | 6.83 | - | 6.83 | - | - |
Net Income to Common | 3.72 | -16.04 | 30.04 | 12.94 | 20.11 | 17.01 |
Net Income Growth | -8.11% | - | 51.98% | -1.69% | 18.17% | 23.00% |
Shares Outstanding (Basic) | 8 | 7 | 9 | 6 | 7 | 5 |
Shares Outstanding (Diluted) | 8 | 7 | 9 | 6 | 7 | 5 |
Shares Change (YoY) | -13.38% | -20.48% | 41.95% | -2.09% | 29.37% | -0.13% |
EPS (Basic) | 0.49 | -2.21 | 3.29 | 2.01 | 3.06 | 3.35 |
EPS (Diluted) | 0.49 | -2.21 | 3.29 | 2.01 | 3.06 | 3.35 |
EPS Growth | -62.59% | - | 63.58% | -34.27% | -8.66% | 23.16% |
Free Cash Flow | -135.84 | -92.79 | -308.37 | -214.75 | -207.26 | -97.06 |
Free Cash Flow Per Share | -17.85 | -12.78 | -33.77 | -33.38 | -31.55 | -19.11 |
Gross Margin | 26.41% | 23.76% | 21.69% | 17.48% | 16.46% | 18.47% |
Operating Margin | 3.78% | 3.36% | 1.37% | 5.26% | 4.28% | 5.81% |
Profit Margin | 0.17% | -0.83% | 2.21% | 0.98% | 1.60% | 1.96% |
Free Cash Flow Margin | -6.18% | -4.82% | -22.64% | -16.21% | -16.55% | -11.19% |
EBITDA | 117.55 | 95.11 | 46.53 | 84.16 | 67.72 | 60.67 |
EBITDA Margin | 5.34% | 4.94% | 3.42% | 6.35% | 5.41% | 6.99% |
D&A For EBITDA | 34.36 | 30.32 | 27.86 | 14.47 | 14.13 | 10.28 |
EBIT | 83.19 | 64.79 | 18.67 | 69.69 | 53.59 | 50.39 |
EBIT Margin | 3.78% | 3.36% | 1.37% | 5.26% | 4.28% | 5.81% |
Effective Tax Rate | 66.83% | 356.35% | - | 34.42% | 28.27% | 34.82% |
Revenue as Reported | 2,225 | 1,939 | 1,367 | 1,328 | 1,260 | 873.61 |
Advertising Expenses | - | 4.32 | 4.74 | 4.37 | 1.67 | 1.32 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.